Search
01/10/2021
Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes
Gimeno-Orna, JA, Rodriguez-Padial, L, Anguita-Sanchez, M, Barrios, V, Muniz, J, Perez, A. Association of the KDIGO Risk Classification with the Prevalence of Heart Failure in Patients with Type 2 Diabetes. Journal of Clinical Medicine. 2021; 10(20)DOI:10.3390/jcm10204634. PMID:34682756. IF:4.964(Q2/4D).
01/10/2021
Randomised Controlled Trials in Diabetes Research: A Pathway to Interpreting Published Results
Battelino, T, Mauricio, D. Randomised Controlled Trials in Diabetes Research: A Pathway to Interpreting Published Results. Diabetes Therapy. 2021; 12(10)DOI:10.1007/s13300-021-01143-6. PMID:34455574. IF:3.605(Q3/7D).
01/10/2021
Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?"
Alvarado-Tapias, E, Vilades, D, Brujats, A, Villanueva, C. Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?". JOURNAL OF HEPATOLOGY. 2021; 75(4)DOI:10.1016/j.jhep.2021.06.026. PMID:34224780. IF:30.083(Q1/1D).
01/10/2021
Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study
Nemirosky, JL, Espelt, R, Grado, EL, Sobrino, J, Acera, A, Perez, J, Jensen, JS, Sanchez-Reus, F, Prim, N. Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(10)DOI:10.1093/jac/dkab224. PMID:34278431. IF:5.758(Q1/2D).
01/10/2021
Prevalence and outcomes of pregnancies in women with HIV over a 20-year period
Kowalska, JD, Pelchen-Matthews, A, Ryom, L, Losso, MH, Trofimova, T, Mitsura, VM, Khromova, I, Paduta, D, Stephan, C, Domingo, P, Bakowska, E, Monforte, AD, Oestergaard, L, Jablonowska, E, Kuznetsova, A, Moreno, S, Vasylyev, M, Pradier, C, Battegay, M, Vandekerckhove, L, Castagna, A, Raben, D, Mocroft, A, EuroSIDA Study Grp. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period. AIDS. 2021; 35(12)DOI:10.1097/QAD.0000000000002954. PMID:34033590. IF:4.632(Q2/5D).
01/10/2021
Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1-Positive Advanced NSCLC
Herbst, RS, Garon, EB, Kim, DW, Cho, BC, Gervais, R, Perez-Gracia, JL, Han, JY, Majem, M, Forster, MD, Monnet, I, Novello, S, Gubens, MA, Boyer, M, Su, WC, Samkari, A, Jensen, EH, Kobie, J, Piperdi, B, Baas, P. Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1-Positive Advanced NSCLC. Research in Social & Administrative Pharmacy. 2021; 16(10)DOI:10.1016/j.jtho.2021.05.001. PMID:34048946. IF:3.348(Q2/5D).